Instruction to Authors

E Journal of Cardiovascular Medicine is published quarterly (March, June, September, December). It aims to publish research articles and reviews of high quality which cover all aspects of surgery of the heart, vessels and chest.

The abbreviation of the E Journal of Cardiovascular Medicine is EJCM.

The authors hold both the scientific and ethical liability, as well as the copyright, for the manuscripts. Commercial rights of the manuscripts are transferred to the Heart and Health Foundation of Turkey. Authors are responsible for the contents of the manuscript and the accuracy of the references. All manuscripts submitted for publication must be accompanied by the Autorship Contribution Form. Once this form, signed by all the authors, is submitted, it is understood that neither the manuscript nor the data it contains have been submitted elsewhere or previously published, and authors declare the statement of scientific contributions and responsibilities of all authors. Abstracts presented at congresses are eligible for evaluation.

E Journal of Cardiovascular Medicine does not charge any article submission or processing fees.

The Editorial Policies and General Guidelines for manuscript preparation specified below are based on ICMJE “Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals” by the International Committee of Medical Journal Editors.

Peer-Review

E Journal of Cardiovascular Medicine is an independent journal based on double-blind peer-review principles. The manuscript is assigned to the Editor-in-Chief, who reviews the manuscript and makes an initial decision based on manuscript quality and editorial priorities. Manuscripts that pass initial evaluation are sent to an Associate Editor. The Associate Editor assigns the manuscript to two reviewers (internal and/or external). The reviewers must review the manuscript within 21 days. The Associate Editor recommends a decision based on the reviewers’ recommendations and sends the manuscript to the Editor-in-Chief. The Editor-in-Chief makes a final decision based on editorial priorities, manuscript quality, and Associate Editor’s and reviewers’ recommendations. If there are any conflicting recommendations from reviewers, the Editor-in-Chief may assign a new reviewer.

All manuscripts submitted are screened for plagiarism using Crossref Similarity Check powered by “iThenticate” software. Results indicating plagiarism may cause manuscripts to be returned or rejected.

Ethic

Experimental, clinical and drug studies requiring approval by an ethics committee must be submitted to the E Journal of Cardiovascular Medicine with an ethics committee approval report confirming that the study was conducted in accordance with international agreements and the Declaration of Helsinki as revised in 2013. The approval of the ethics committee and the fact that informed consent was given by the patients should be indicated in the Materials and Methods section. In experimental animal studies, the authors should indicate that the procedures followed were in accordance with animal rights as per the Guide for the Care and Use of Laboratory Animals, and they should obtain animal ethics committee approval.

The presentation of the article types must be designed in accordance with trial reporting guidelines:

Human research: Helsinki Declaration as revised in 2013

Systematic reviews and meta-analyses: PRISMA guidelines, Systematic Reviews and Meta-Analyses Guidelines

Case reports: the CARE case report guidelines

Clinical trials: CONSORT

Animal studies: ARRIVE and Guide for the Care and Use of Laboratory Animals

Authors must provide disclosure/acknowledgement of financial or material support if any is received.

If the article includes any direct or indirect commercial links or if any institution provided material support to the study, authors must state in the cover letter that they have no relationship with the commercial product, drug, pharmaceutical company, etc. concerned; or specify the type of relationship (consultant, other agreements).

Authors must provide a statement on the absence of conflicts of interest among the authors and provide authorship contributions.

In case of any suspicion or claim regarding scientific shortcomings or ethical infringement, the journal reserves the right to submit the manuscript to the supporting institutions or other authorities for investigation. The Journal accepts the responsibility of initiating action but does not undertake any responsibility for an actual investigation or any power of decision.

Guidelines

Manuscripts can only be submitted electronically through EJManager website (https://www.ejmanager.com/my/ejcm/) after creating an account.

Format: Manuscripts should be prepared using Microsoft Word; font type and font size should preferably be Arial or Times New Roman 11 points. The manuscript should be double-spaced and should include line and page numbers.

Abbreviations: Abbreviations should be defined at first mention and used consistently thereafter. Internationally accepted abbreviations should be used; refer to scientific writing guides as necessary.

Cover letter: A cover letter should be enclosed to all new manuscripts (to be filled in online), specifying the name of the journal and the type of paper, and including the following statements:

1. The manuscript should not be previously published in print or electronic form and is not under consideration by another publication.
2. All authors should contribute to the content of the article.
3. All authors should read and approve the submission of the manuscript to EJCM.
4. Subject to acceptance, authors will sign an exclusive license to publish.

Submitted revisions must have all changes marked in red.

All submitted articles must be accompanied by the following files:

Title Page: This page should include the title of the manuscript, name(s) of the authors and author information. The following descriptions should be stated in the given order:

1. The title should be brief and descriptive (100 characters) – no abbreviations are allowed, even if well known.
2. List all authors by full first name, initial or full middle name and family name. Qualifications are not required. Ensure the author names correspond (in spelling and order of appearance) with the metadata of the system.
3. Include the name of all institutions with the location (department, institution, city, country) to which the work should be attributed (in English). Use superscript numbers to connect authors and their department or institution.
4. Name, address, e-mail, phone and fax number of the corresponding author
5. If the manuscript was (or will be) presented at a meeting, include the meeting name, venue, and the date on which it was (or will be) presented; also indicate if you have submitted an Abstract of this manuscript for the EACTS or ESTS annual meeting and whether it has been accepted (if known).

Abstract: It should be a concise summary of the manuscript. Reference citations are not allowed. The abstract should be factual and free of abbreviations, except for SI units of measurement. It should be in English, with a minimum of 150 and a maximum of 350 words.

For original articles, the structured abstract should include the following sub-headings:

Objectives: The aim of the study should be clearly stated.

Materials and Methods: The study and standard criteria used should be defined; it should also be indicated whether the study is randomized or not, whether it is retrospective or prospective, and the statistical methods applied should be indicated, if applicable.

Results: The detailed results of the study should be given, and the statistical significance level should be indicated.

Conclusion: Should summarize the results of the study, the clinical applicability of the results should be defined, and the favourable and unfavourable aspects should be declared.

Keywords: A list of minimum 3, but no more than 6 keywords must follow the abstract. Keywords should be consistent with “Medical Subject Headings” (MESH).

Original Articles

Clinical research should comprise clinical observation, new techniques or laboratory studies. Original research articles should include title, structured abstract, keywords relevant to the content of the article, introduction, materials and methods, results, discussion, references, tables/figures and acknowledgement sections. The manuscript should be formatted in accordance with the above-mentioned guidelines and should not exceed 3000 words.

Clinical Trial Policy

All clinical trials, which are any research projects that prospectively assign individuals or a group of people to an intervention, with or without concurrent comparison or control groups, in order to study the relationship between a health-related intervention and a health outcome, must be registered in a public trials registry acceptable to the International Committee of Medical Journals Editors (ICMJE). Authors of randomized controlled trials must adhere to the CONSORT guidelines , and provide both a CONSORT checklist (for protocols, see the SPIRIT guidance) and flow diagram. We require that you choose the MS Word template at www.consort-statement.org for the flow chart and cite/upload it in the manuscript as a figure. In addition, submitted manuscripts must include the unique registration number in the Abstract as evidence of registration.  The Clinical Trial Registration Policy has been implemented in our journal as of September 2023. For more detailed instructions regarding clinical trials, please visit the guideline below:

Clinical Trials Guidelines

You can register for clinical trials by visiting the following link:
https://clinicaltrials.gov/

To register the relevant record in the system and learn more about the protocol to be followed, please review the link below:
https://classic.clinicaltrials.gov/ct2/manage-recs/how-register

The other registries are accepted by ICJME:
www.anzctr.org.au
www.ISRCTN.org
www.umin.ac.jp/ctr/index/htm
www.onderzoekmetmensen.nl/en
https://eudract.ema.europa.eu/

Introduction: Should state the purpose of the investigation and give a short review of pertinent literature.

Materials and Methods: This should be described in detail with appropriate information about patients or experimental animals. The use of abbreviations renders the text difficult to read; abbreviations should be limited to SI units of measurement and to those most commonly used, e.g. VSD, ASD, CABG (abbreviations should not be included in headings and extensions should be included at first mention).

Results: Results should be reported concisely and regarded as an important part of the manuscript. They should be presented either in tables and figures and briefly commented on in the text or in the text alone. Repetition of results should be avoided.

Discussion: The discussion is an interpretation of the results and their significance with reference to pertinent work by other authors. It should be clear and concise.

Acknowledgements: Acknowledgements and details of non-financial support must be included at the end of the text before the references. Personal acknowledgements should precede those of institutions or agencies.

References: The number of references should not exceed 40. Authors are responsible for the accuracy of the references. See References section for details about the usage and formatting required.

Case Reports

Case reports should present cases that are rarely seen, new surgery techniques, feature novelty in diagnosis and treatment, and contribute to our current knowledge. The first page should include the title, an unstructured abstract not exceeding 250 words, and keywords. The main text should not exceed 1500 words and consist of an introduction, case report, discussion and references not exceeding 20.

Review Articles

Review articles must provide critical analyses of contemporary evidence and provide directions for current or future research. Reviews articles analyze topics in-depth, independently and objectively. The first page should include the title, an unstructured abstract and keywords. The source of all citations should be indicated and the references amount should not exceed 100. The main text should not exceed 5000 words.

References

Authors are responsible for the accuracy and completeness of their references and for correct in-text citation. All references should be in accordance with the following rules:

In-text citations: References should be indicated as superscripts in the parentheses after the full stop of the relevant sentence. If the author(s) of a reference is/are indicated at the beginning of the sentence, this citation should be written as superscript in the parentheses immediately after the author’s name.

References section: References should be numbered consecutively in the order in which they are first mentioned in the text. If there are more than 6 authors, the first 3 authors must be listed, followed by “et al.”. The titles of journals should be abbreviated according to the style used in the Index Medicus. If a reference from another language than English will be used, the English version of the title should be referenced.

Reference Format

Journal: Sawhney N, Anousheh R, Chen WC, Narayan S, Feld GK. Five-Year Outcomes After Segmental Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation. Am J Cardiol 2009;104:366–72.

Book: Baue AE, Geha AS, Hammond GL, Laks H, Naunheim KS. Gleen’s thoracic and cardiovascular surgery. 1st ed. London: Appleton&Lange; 1991.

Book Chapter: Weinberg PM. Aortic arch anomalies. In: Allen HD, Clark EB, Gutgesell HP, Driscoll DJ (eds). Moss and Adams’ heart disease in ınfants, children, and adolescents. 1st ed. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 707-735.

Conference Paper: Davis L, Lee M, Sheridan B, et al. Berlin Heart EXCOR support in the first year of life. In: 32nd EACTS Annual Meeting; 18-20 October, 2018; Milan, Italy.

Figures and Tables

All visual materials (pictures, graphs and drawn figures) must be named as “Figure”. All figures and tables must be cited within the main text consecutively. Legends of all figures must be submitted as separate pages of the main document. Each figure must be submitted as a separate file and in “.jpeg” format. All figures should be of the possibly highest quality and at a minimum resolution of 300 dpi. All figures must be original. Figures previously published by other sources must be submitted with a copy of the written permission of the owner of the figure. All permissions must be obtained by authors prior to submission. For figures involved in human studies, written informed consent must be taken from the patient or his/her parent and uploaded during submission. Otherwise, patients’ names must not be indicated, and their eyes must be hidden with black lines to prevent any exposure of identity.

All tables must be included in the manuscript file, should start on separate pages and be accompanied by a title and footnotes where necessary. The tables should be numbered consecutively using Arabic numerals. Units in which results are expressed should be given in parentheses at the top of each column and not repeated in each line of the table.

Informed Consent and Ethics

A manuscript reporting the results of experimental investigations on human subjects must include a statement in the Materials and Methods section that the institutional review board has approved the study and the informed consent were obtained from patient or parents. The author(s) should state the accordance with the Declaration of Helsinki. Also, the experimental studies must be approved by the ethics committee for animal use and proper ethics.

Correspondence

Heart and Health Foundation of Turkey
Address: Şair Eşref Bulvarı, 1402 Sk. No. 2/2 Özbaş Apt. Alsancak – İZMİR / TURKEY
Phone: +90 232 464 19 63
Fax: +90 232 464 24 70
E-mail: [email protected]

Requests for permission to reproduce published material should be sent to the publisher.

Publisher: Galenos Publishing House
Adress: Molla Gürani Mah. Kaçamak Sok. 21/1 Fındıkzade, Fatih, Istanbul, Turkey
Telephone: +90 212 621 99 25
Fax: +90 212 621 99 27
Web page: http://www.galenos.com.tr
E-mail: [email protected]